SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-24-107128
Filing Date
2024-04-23
Accepted
2024-04-23 16:34:57
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFA14A d675436ddefa14a.htm DEFA14A 20639
2 GRAPHIC g675436dsp3.jpg GRAPHIC 844
3 GRAPHIC g675436dsp4.jpg GRAPHIC 41702
4 GRAPHIC g675436dsp4a.jpg GRAPHIC 43988
5 GRAPHIC g675436dsp5.jpg GRAPHIC 872
  Complete submission text file 0001193125-24-107128.txt   142689
Mailing Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451
Business Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38443 | Film No.: 24865298
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)